(CIDRAP News) – The US Centers for Disease Control and Prevention (CDC) takes a hit of about $270 million in the Obama administration's proposed fiscal year 2014 budget, including significant cuts to biodefense and emergency preparedness programs, officials revealed today.
(CIDRAP News) Responding to lobbying by the Obama administration and public health advocates, Congress last week approved $7.65 billion for battling pandemic influenza, more than three times what the House and Senate had earlier proposed.
(CIDRAP News) Cost issues and the risk of viral resistance drew considerable attention today in an online presentation by federal health officials on their revised guidance regarding use of antiviral drugs in an influenza pandemic.
The Department of Health and Human Services (HHS) released two guidance documents this week, one on antiviral use in general and one on employer stockpiling of antivirals.
(CIDRAP News) The US Department of Health and Human Services (HHS) today hosted an online conversation among experts, government officials, and members of the public that touched on emerging issues in pandemic planning, such as anticipating supply chain interruptions and keeping the momentum going during tough economic times.
(CIDRAP News) GlaxoSmithKline, maker of the antiviral drug zanamivir (Relenza), today launched a program designed to help businesses stockpile the drug as a strategy to protect employees in the event of an influenza pandemic.
(CIDRAP News) With an endorsement from US health officials, Roche, maker of the antiviral drug oseltamivir (Tamiflu), today unveiled a program to encourage more businesses to stockpile the drug to protect employees in case of an influenza pandemic.